Saturday, 17 December 2022

DCGI Approves BE’s 14-Valent Pneumococcal Conjugate Vaccine

DCGI Approves BE’s 14-Valent Pneumococcal Conjugate Vaccine
DCGI Approves BE’s 14-Valent Pneumococcal Conjugate Vaccine
Rajesh Vagh Sat, 12/17/2022 - 15:17

Biological E. Limited Receives Authorization to Manufacture and Market the 14-valent Vaccine against Streptococcus pneumoniae Infection in India



source https://www.pharmatutor.org/pharma-news/2022/dcgi-approves-be-14-valent-pneumococcal-conjugate-vaccine
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...